99% Savings - Buy Just @1 Rs X
Secnil Injection, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Amebiasis. Secondary and off-label uses of Secnil Injection have also been mentioned below.
The right dosage of Secnil Injection depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Secnil Injection include Vaginal itching, Vaginal discharge. While these are the most often observed Secnil Injection side effects, there are can be others also. These have been listed below. Usually, these side effects of Secnil Injection go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Secnil Injection's effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Secnil Injection related warnings talks about Secnil Injection's effects on the liver, heart and kidney.
Secnil Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Secnil Injection in conditions like Anemia. Some other conditions that can be affected by Secnil Injection are listed in the contraindications section below.
Drug interactions for Secnil Injection have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Secnil Injection is not safe while driving, and is is not addictive in nature.
Secnil Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Secnil Injection safe for pregnant women?
Secnil may have some side effects during pregnancy. Pregnant women should discontinue the use of Secnil, and talk to their doctor, if they notice any discomfort.
Is the use of Secnil Injection safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Secnil. Immediately discontinue Secnil if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Secnil Injection on the Kidneys?
Secnil may have mild side effects on the kidneys.
What is the effect of Secnil Injection on the Liver?
Secnil is rarely harmful for the liver.
What is the effect of Secnil Injection on the Heart?
There are no any side effects of Secnil for the heart.
If you are suffering from any of the following diseases, you should not take Secnil Injection unless your doctor advises you to do so -
Is this Secnil Injection habit forming or addictive?
Forming a habit of Secnil Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Secnil Injection can make you feel drowsy.
Is it safe?
Yes, but consume Secnil Injection only on doctor's advice.
Is it able to treat mental disorders?
No, Secnil Injection is not used to treat mental disorders.
Interaction between Food and Secnil Injection
It is safe to take Secnil Injection with food.
Interaction between Alcohol and Secnil Injection
Consult your doctor before consuming alcohol while taking Secnil Injection as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Solosec (secnidazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 839